Doctors'Scrubs Dress

Uncas Ben Favret, biotech industry entrepreneur, had a view about high-tech textiles. He analyzes why doctors and nurses still put on scrubs and lab coats made from unrefined cotton blends? According to the study of Centers for Disease Control and Prevention, Errant microbes afflict the recent medical facilities. When pathogens multiply inside hospitals, the costs of the facilities are $30 billion and an estimated 1.7 million infections and nearly 100,000 deaths had arisen.

A simple solution is the use of germ-killing and fluid-resistant uniforms. Vestagen Technical Textiles will solve the problem. Vestagen Technical Textiles is under the brand name Vestex which was launched last year in Orlando. About $5 million capital was sow by its inventors. The chemical compound called organosilane forms a colorless, odorless, positively charged barrier on the fabric's surface. It is a licensed technology called NanoSphere, from Schoeller Textiles in Switzerland. When you look at it it's like a layer of electrically charged swords so when the bacteria enters the fabric, it perforates their cell membranes and kills them with an electrical charge. Vestagen donated scrubs for emergency medical workers like Wilma Schmidt did when she volunteered to treat earthquake survivors in Haiti. Vestex uniforms are more expensive than regular scrubs or lab coats. Its scrub tops retail for $24 to $26, while conventional scrub tops cost $20 per piece. Mercy Health Partners in Knoxville, Tenn. had purchased 600 Vestex lab coats for its doctors. They believe that physicians bring in bacteria from their ties and lab coats coz they are happy to give up the tie, but the lab coat identifies them as a physician. The Vestex coats are effective against a lot of different bacteria.

Vestagen started its operation last January. The company already gained $500,000 revenue. The company also sells quarantine curtains, sheets, towels, patient gowns and blankets. Favret stated that more than $6 million revenue is expected this year. [via money.cnn.com]